This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Although the most common site of MBC is bone, there is currently no standardized imagingmodality that offers accurate assessment of bone treatment response, Masperi and Girlando explained. To mitigate these effects, low-energy imaging techniques should be prioritized without compromising diagnostic accuracy.
Hospitals and medical practices of all sizes, no matter their target demographic or geographical location, often struggle to ensure their patients have access to all of the essential imagingmodalities necessary to diagnose a wide variety of medical conditions.
To design the salvage radiation therapy, imaging is required to detect and locate the recurrence disease regime.” “In those scenarios, salvage radiation therapy is often offered to patients as a treatment option.
Prostate-specific membrane antigen (PSMA)-PET/CT bests conventional imaging when it comes to identifying high-risk, nonmetastatic, hormone-sensitive prostate cancer, researchers have reported.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content